SCOLR Pharma, Inc. 4
4 · SCOLR Pharma, Inc. · Filed Dec 21, 2004
Insider Transaction Report
Form 4
VITULLI GAIL
Dir of Finance/Princ Finl Ofcr
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2004-12-17−10,000→ 5,000 totalExercise: $0.66Exp: 2011-02-08→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2004-12-17$0.66/sh+10,000$6,600→ 25,000 total
Footnotes (2)
- [F1]The option was exercisable as to one-sixth (1/6) of the total shares on 8/9/2001, which was the end of the six month period following the date of grant, as to an additional one-sixth (1/6) of the total shares at the end of the subsequent six month period, and as to an additional one-third (1/3) of the total shares at the end of each subsequent twelve month period.
- [F2]Not applicable.